| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $397.2M | $443.2M | $565.2M |
| YoY Revenue Growth % | -10.4% | -21.6% | — |
| Gross Profit | $73.3M | $96.7M | — |
| Gross Margin % | 18.4% | 21.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$125.7M | -$41.9M | -$88.0M |
| Operating Margin % | -31.6% | -9.5% | -15.6% |
| Net Income (GAAP) | -$137.5M | -$42.8M | -$107.7M |
| EBITDA (Normalized) | -$118.5M | -$33.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$38.0M | $31.9M | $66.5M |
| Capital Expenditures (CapEx) | $9.0M | $10.4M | — |
| Free Cash Flow (FCF) | -$47.1M | $21.5M | $66.5M |
| FCF Margin % | -11.8% | 4.8% | 11.8% |
| Return on Invested Capital (ROIC %) | -45.0% | -15.4% | — |
| Cash & Short-Term Equivalents | $58.4M | $57.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $139.2M | $271.6M | — |